Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
300760
株式のランク
#786
Operating on a global scale, Shenzhen Mindray Bio-Medical Electronics Co., Ltd.... Operating on a global scale, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. specializes in providing a comprehensive range of medical devices and innovative healthcare solutions. Its extensive portfolio encompasses several key segments. Within patient monitoring and life support, the company manufactures crucial equipment such as patient monitoring systems, electrocardiographs, defibrillators, anesthesia machines, ventilators, infusion pumps, surgical lights, operating tables, medical supply units, and endoscopes, along with associated accessories. This segment also delivers integrated solutions for emergency care, peri-operative management, critical care, and medical IT systems. For in-vitro diagnostics, Mindray offers sophisticated products including hematology and chemistry analyzers and their reagents, chemiluminescence immunoassay products, hemoglobin systems, flow cytometry instruments, and microplate readers and washers. These are further supported by solutions tailored for coagulation, urinalysis, and microbiology. The company additionally produces advanced medical imaging systems, covering both ultrasound and radiology products, and supplies a dedicated line of veterinary products. Founded in 1991, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. maintains its primary operational base in Shenzhen, People's Republic of China.
株価
$25.47
時価総額
$30.86B
変化（1日）
3.53%
変化（1年）
-18.86%
国
CN
取引 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760)
カテゴリー
Healthcare
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.（300760）のP/E比率
October 2026 時点のP/E比率 TTM 25.73
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. の最新の財務報告および株価によると、現在の P/E (TTM) は 25.73 です。2023 年末時点での P/E は 30.70 でした。
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. の P/E 比率の履歴（2014 〜 2026）
各年末のP/E比率
| 年 | P/E比率 | 変化 |
|---|---|---|
| 2026 (TTM) | 25.73 | -2.75% |
| 2024 | 26.46 | -13.80% |
| 2023 | 30.70 | -22.85% |
| 2022 | 39.79 | -31.17% |
| 2021 | 57.81 | -25.68% |
| 2020 | 77.79 | 64.65% |
| 2019 | 47.24 | 48.75% |
| 2018 | 31.76 | 7.12% |
| 2017 | 29.65 | -32.07% |
| 2016 | 43.65 | -39.13% |
| 2015 | 71.70 | 50.00% |
| 2014 | 47.80 | 0.00% |
類似企業や競合他社のP/E比率
| 企業 | P/E比率 | P/E比率の差 | 国 |
|---|---|---|---|
| 33.11 | 28.67% |
US
|
|
| 21.39 | -16.88% |
IE
|
|
| 28.94 | 12.48% |
US
|
|
| 17.34 | -32.62% |
US
|
|
| - | - |
DE
|
P/E比率の読み方
株価収益率（P/E Ratio）は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の（0に近い）P/Eは、損失が大きいことを示します。
P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。
10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。